AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) return on equity

annual ROE:

-100.88%-113.61%(-892.46%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual return on equity is -100.88%, with the most recent change of -113.61% (-892.46%) on December 31, 2024.
  • During the last 3 years, AMLX annual ROE has risen by +87.17% (+46.35%).
  • AMLX annual ROE is now -230.05% below its all-time high of 77.57%, reached on December 31, 2019.

Performance

AMLX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXprofitability metrics

quarterly ROE:

-94.60%+0.71%(+0.74%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly return on equity is -94.60%, with the most recent change of +0.71% (+0.74%) on June 1, 2025.
  • Over the past year, AMLX quarterly ROE has dropped by -49.13% (-108.05%).
  • AMLX quarterly ROE is now -841.96% below its all-time high of 12.75%, reached on December 31, 2023.

Performance

AMLX quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AMLX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-892.5%-108.0%
3 y3 years+46.4%-8.2%
5 y5 years-230.1%+41.2%

AMLX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-892.5%+46.4%-842.0%+14.4%
5 y5-year-230.1%+87.3%-842.0%+88.8%
alltimeall time-230.1%+87.3%-842.0%+88.8%

AMLX ROE History

DateAnnualQuarterly
Jun 2025
-
-94.60%(-0.7%)
Mar 2025
-
-95.31%(-12.8%)
Dec 2024
-100.88%(-892.5%)
-109.32%(+37.7%)
Sep 2024
-
-79.41%(+74.6%)
Jun 2024
-
-45.47%(+145.0%)
Mar 2024
-
-18.56%(-245.6%)
Dec 2023
12.73%
12.75%(+2176.8%)
Sep 2023
-
0.56%(-102.2%)
Jun 2023
-
-25.70%(-56.1%)
DateAnnualQuarterly
Mar 2023
-
-58.60%(-40.5%)
Dec 2022
-92.53%(-50.8%)
-98.54%(-10.8%)
Sep 2022
-
-110.53%(+26.4%)
Jun 2022
-
-87.47%(+46.7%)
Mar 2022
-
-59.62%(-18.9%)
Dec 2021
-188.05%(-76.3%)
-73.47%(-91.3%)
Jun 2021
-
-843.86%(+94.8%)
Mar 2021
-
-433.11%(+169.0%)
Dec 2020
-792.21%(-1121.3%)
-160.99%
Dec 2019
77.57%
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual return on equity?
  • What is the all time high annual ROE for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of AMLX is -100.88%

What is the all time high annual ROE for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual return on equity is 77.57%

What is Amylyx Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, AMLX annual return on equity has changed by -113.61% (-892.46%)

What is Amylyx Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of AMLX is -94.60%

What is the all time high quarterly ROE for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly return on equity is 12.75%

What is Amylyx Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, AMLX quarterly return on equity has changed by -49.13% (-108.05%)
On this page